enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Seirogan - Wikipedia

    en.wikipedia.org/wiki/Seirogan

    Seirogan (Japanese: 正露丸, formerly 征露丸) is a pharmaceutical drug marketed in Japan as a treatment for the digestive tract (especially as an antidiarrhoeal), whose main active ingredient is "wood creosote" (also wood-tar creosote, or beechwood creosote [1]).

  3. Cyclobenzaprine - Wikipedia

    en.wikipedia.org/wiki/Cyclobenzaprine

    Cyclobenzaprine, sold under several brand names including, historically, Flexeril, is a muscle relaxer used for muscle spasms from musculoskeletal conditions of sudden onset. [5]

  4. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  5. Pentobarbital - Wikipedia

    en.wikipedia.org/wiki/Pentobarbital

    Pentobarbital was widely abused beginning in the late 1930s and sometimes known as "yellow jackets" due to the yellow color of Nembutal-branded capsules. [7] Pentobarbital in oral (pill) form is not commercially available. [4] [failed verification] Pentobarbital was developed by Ernest H. Volwiler and Donalee L. Tabern at Abbott Laboratories in ...

  6. Cialis and Alcohol: Is it Safe?

    www.aol.com/cialis-alcohol-safe-115800912.html

    How Cialis Works. Cialis is a prescription medication designed to treat ED. It’s approved for this use by the U.S. Food and Drug Administration (FDA). Tadalafil is the active ingredient in Cialis.

  7. Dexamyl - Wikipedia

    en.wikipedia.org/wiki/Dexamyl

    Dexamyl (or Drinamyl in the UK) was the brand name of a combination drug composed of amobarbital (previously called amylbarbitone) and dextroamphetamine (Dexedrine) within the same pill. It was widely abused and is no longer manufactured. [1]

  8. Exclusive-US FDA finds widely used asthma drug impacts ... - AOL

    www.aol.com/news/exclusive-us-fda-finds-widely...

    Singulair was a blockbuster product for Merck after its launch in 1998, offering relief in a pill as an alternative to an inhaler. In early advertising, the company said the side effects were so ...

  9. Consulting firm McKinsey to pay $650 million to resolve US ...

    www.aol.com/news/consulting-firm-mckinsey-pay...

    BOSTON (Reuters) -McKinsey & Co has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm's work advising opioid manufacturer OxyContin maker ...